An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice
Open Access
- 1 January 1996
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 39 (3) , 185-188
- https://doi.org/10.1016/0361-9230(95)02092-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Opioid peptide receptor studies. 1. Identification of a novel δ-opioid receptor binding site in rat brain membranesPeptides, 1995
- Levels of Delta-Opioid Receptor mRNA in Morphine-Tolerant MiceAnalgesia, 1995
- Treatment with antisense oligodeoxynucleotide to the opioid δ receptor selectively inhibits δ2-agonist antinociceptionNeuroReport, 1994
- Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptorNeuron, 1994
- Characteristics of μ and δ opioid binding sites in striatal slices of morphine-tolerant and -dependent miceEuropean Journal of Pharmacology, 1991
- Naltrindole-5'-isothiocyanate: a nonequilibrium, highly selective .delta.-opioid receptor antagonistJournal of Medicinal Chemistry, 1990
- Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonistEuropean Journal of Pharmacology, 1988
- Morphine tolerance increases μ-noncompetative δ binding sitesEuropean Journal of Pharmacology, 1986
- ICI 174864: A highly selective antagonist for the opioid Δ-receptorEuropean Journal of Pharmacology, 1984
- Repeated electroconvulsive shock or chronic morphine treatment increases the number of 3HDALA2, DLEU5enkephalin binding sites in rat brain membranesLife Sciences, 1982